Stéphanie Tissot-Renaud
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Stéphanie Tissot-Renaud has a total of 296 co-authors. Here are the top co-authors by number of shared publications:
- Christine Pich-Bavastro
Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne Switzerland
95 shared publications - François Kuonen
Department of Dermatology and Venereology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
95 shared publications - Jeremy Di Domizio
Department of Dermatology Lausanne University Hospital CHUV and University of Lausanne Lausanne Switzerland
95 shared publications - Laura Yerly
Department of Dermatology and Venereology, Lausanne University Hospital and University of Lausanne , Lausanne
95 shared publications - Michel Gilliet
Department of Dermatology, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland
95 shared publications - Sylvie Rusakiewicz
IMMUcan Consortium, Brussels, Belgium
36 shared publications
Latest Publications
- Open Access
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S2. Study workflow and multi-omics approach
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S2. Study workflow and multi-omics approach
- Open Access
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S10 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S10. p-EMT and TLS signatures are prognostic factors in R/M SCCHN
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S10 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S10. p-EMT and TLS signatures are prognostic factors in R/M SCCHN
- Open Access
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S3. Three multiplex immunofluorescent staining of SCCHN samples with 3 different 6-plex panels and their deconvolution
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S3. Three multiplex immunofluorescent staining of SCCHN samples with 3 different 6-plex panels and their deconvolution
- Open Access
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S6. Genomic and transcriptomic alterations linked to HPV status
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S6. Genomic and transcriptomic alterations linked to HPV status
- Open Access
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S4. FFPE vs frozen tumor biopsies comparisons
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S4. FFPE vs frozen tumor biopsies comparisons
- Open Access
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S5. HPV status affects the genomic and transcriptomic profiles but not the immune infiltration
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S5. HPV status affects the genomic and transcriptomic profiles but not the immune infiltration
- Open Access
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S7. Genomic alterations associated with substance abuse and primary disease location.
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S7 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S7. Genomic alterations associated with substance abuse and primary disease location.
- Open Access
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S9 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S9. The treatment history has an impact on the molecular and immune landscape of R/M SCCHN, related to Figure 3.
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S9 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S9. The treatment history has an impact on the molecular and immune landscape of R/M SCCHN, related to Figure 3.
- Open Access
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S8 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S8. No differences in immune proportions according to disease extent
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S8 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S8. No differences in immune proportions according to disease extent